Histogenics Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Histogenics Corporation - overview
Established
2000
Location
Waltham, MA, US
Primary Industry
Biotechnology
About
Histogenics Corporation engages in the development and commercialization of regenerative medicine products, focusing on cartilage repair and tissue regeneration therapies for orthopedic applications. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, US. The company specializes in regenerative medicine, particularly in cartilage repair and tissue regeneration. The most recent investment was a PIPE round in December 2014, raising USD 0.
03 mn, which contributed to a total amount raised of USD 0. 03 mn. The firm has executed 12 deals to date and has not undergone any notable changes in its business strategy or operations. Histogenics Corporation's primary offerings involve regenerative medicine products aimed at enhancing cartilage repair and regeneration in orthopedic applications.
These products are designed to improve patient outcomes through innovative treatments that promote healing and recovery. In 2018, Histogenics Corporation reported a revenue of USD 0 mn and an EBITDA of USD -29,658,000. Histogenics Corporation plans to leverage its recent funding from the PIPE round in December 2014 to support the development and commercialization of new regenerative products. The company aims to expand its market presence in North America and Europe, with specific targets for new product launches in the next two years, enhancing its portfolio in cartilage repair therapies.
Current Investors
Ocugen, Inc., Boston Millennia Partners, Foundation Medical Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.histogenics.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Histogenics Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Histogenics Corporation | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.